Trump's Executive Order on Psychedelics Seen as Validation for Investors
President Donald Trump's executive order on psychedelics has led to a significant rise in stocks of companies in the sector, with some shares surging as much as 187% in premarket trading. Jefferies analyst Andrew Tsai described the order as an 'official stamp of validation,' signaling increased credibility for psychedelic therapies as a treatment for mental illness.
Tickers: $ATAI $CMPS $COMP $GHRS
Topics: executive_orders investor_sentiment psychedelic_drugs stock_market_reaction